|
|
||||||||
increases tyrosine phosphorylation of vascular endothelial cadherin and opens the paracellular pathway through fyn activation in human lung endothelia
Divisions of Infectious Disease and Pulmonary and Critical Care Medicine, Departments of Medicine and Pathology, and Mucosal Biology Research Center, University of Maryland School of Medicine, Baltimore, Maryland
Submitted 25 March 2006 ; accepted in final form 25 July 2006
Tumor necrosis factor (TNF)-
is a key mediator of sepsis-associated multiorgan failure, including the acute respiratory distress syndrome. We examined the role of protein tyrosine phosphorylation in TNF-
-induced pulmonary vascular permeability. Postconfluent human lung microvascular and pulmonary artery endothelial cell (EC) monolayers exposed to human recombinant TNF-
displayed a dose- and time-dependent increase in transendothelial [14C]albumin flux in the absence of EC injury. TNF-
also increased tyrosine phosphorylation of EC proteins, and several substrates were identified as the zonula adherens proteins vascular endothelial (VE)-cadherin, and
-catenin,
-catenin, and p120 catenin (p120ctn). Prior protein tyrosine kinase (PTK) inhibition protected against the TNF-
effect. TNF-
activated multiple PTKs, including src family PTKs. Prior PTK inhibition with the src-selective agents PP1 and PP2 each protected against
60% of the TNF-
-induced increment in [14C]albumin flux. PP2 also blocked TNF-
-induced tyrosine phosphorylation of VE-cadherin,
-catenin, and p120ctn. To identify which src family kinase(s) was required for TNF-
-induced vascular permeability, small interfering RNA (siRNA) targeting each of the three src family PTKs expressed in human EC, c-src, fyn, and yes, were introduced into the barrier function assay. Only fyn siRNA protected against the TNF-
effect, whereas the c-src and yes siRNAs did not. These combined data suggest that TNF-
regulates the pulmonary vascular endothelial paracellular pathway, in part, through fyn activation.
acute respiratory distress syndrome; endothelial barrier function; zonula adherens; src
This article has been cited by other articles:
![]() |
M. I. Hermanns, J. Kasper, P. Dubruel, C. Pohl, C. Uboldi, V. Vermeersch, S. Fuchs, R. E. Unger, and C. J. Kirkpatrick An impaired alveolar-capillary barrier in vitro: effect of proinflammatory cytokines and consequences on nanocarrier interaction J R Soc Interface, September 30, 2009; (2009) rsif.2009.0288.focusv1. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Mathew, D. Haubert, M. Kronke, and M. Leptin Looking beyond death: a morphogenetic role for the TNF signalling pathway J. Cell Sci., June 15, 2009; 122(12): 1939 - 1946. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-M. Heupel, A. Efthymiadis, N. Schlegel, T. Muller, Y. Baumer, W. Baumgartner, D. Drenckhahn, and J. Waschke Endothelial barrier stabilization by a cyclic tandem peptide targeting VE-cadherin transinteraction in vitro and in vivo J. Cell Sci., May 15, 2009; 122(10): 1616 - 1625. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Chang, L. G. Chicoine, H. Cui, N. L. Kanagy, B. R. Walker, Y. Liu, B. K. English, and L. D. Nelin Cytokine-induced arginase activity in pulmonary endothelial cells is dependent on Src family tyrosine kinase activity Am J Physiol Lung Cell Mol Physiol, October 1, 2008; 295(4): L688 - L697. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Dejana, F. Orsenigo, and M. G. Lampugnani The role of adherens junctions and VE-cadherin in the control of vascular permeability J. Cell Sci., July 1, 2008; 121(13): 2115 - 2122. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. D. Mruk, B. Silvestrini, and C. Y. Cheng Anchoring Junctions As Drug Targets: Role in Contraceptive Development Pharmacol. Rev., June 1, 2008; 60(2): 146 - 180. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Heyraud, M. Jaquinod, C. Durmort, E. Dambroise, E. Concord, J. P. Schaal, P. Huber, and D. Gulino-Debrac Contribution of Annexin 2 to the Architecture of Mature Endothelial Adherens Junctions Mol. Cell. Biol., March 1, 2008; 28(5): 1657 - 1668. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Gertzberg, T. Gurnani, P. Neumann, A.-K. Forbes, N. Jean-Louis, and A. Johnson Tumor necrosis factor-{alpha} causes barrier dysfunction mediated by tyrosine198 and tyrosine218 in beta-actin Am J Physiol Lung Cell Mol Physiol, November 1, 2007; 293(5): L1219 - L1229. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Gillrie, G. Krishnegowda, K. Lee, A. G. Buret, S. M. Robbins, S. Looareesuwan, D. C. Gowda, and M. Ho Src-family kinase dependent disruption of endothelial barrier function by Plasmodium falciparum merozoite proteins Blood, November 1, 2007; 110(9): 3426 - 3435. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. C. McGown and Z. L. S. Brookes Beneficial effects of statins on the microcirculation during sepsis: the role of nitric oxide Br. J. Anaesth., February 1, 2007; 98(2): 163 - 175. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |